DJIA 16,896.12 -64.45 -0.38%
NASDAQ 4,426.05 -23.51 -0.53%
S&P 500 1,967.55 -10.79 -0.55%
market minute promo

Sinovac Biotech Ltd. (NASDAQ: SVA)

5.50 -0.05 (-0.90%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

SVA $5.50 -0.90%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $5.54
Previous Close $5.55
Daily Range $5.50 - $5.55
52-Week Range $3.85 - $8.14
Market Cap $305.6M
P/E Ratio 42.69
Dividend (Yield) $0.00 (0.0%)
Volume 18,377
Average Daily Volume 179,726
Current FY EPS -$0.06

Sector

Healthcare

Industry

Drugs

Sinovac Biotech Ltd. (SVA) Description

A biopharmaceutical company which is in the business of research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases. Website: http://www.sinovac.com/

News & Commentary Rss Feed

Why Sinovac, Pluristem, and Synta Could Be Worth Watching Today

Sinovac, Pluristem, and Synta Pharmaceuticals might all be worth a look today. Let's take a look at the headlines that could move these three stocks.

Exclusive: Sinovac IR Director Explains Massive Revenue Opportunity

UPDATE: Morgan Stanley Reiterates On Sinovac Biotech Ltd. Following Solid 1Q14 EPS

Sinovac Biotech's (SVA) CEO Weidong Yin on Q1 2014 Results - Earnings Call Transcript

China Biotech Week In Review: Pfizer's Attempt To Acquire AstraZeneca Could Run Into Trouble

Sinovac Biotech Ltd. Stock Downgraded (SVA)

Sinovac Biotech (SVA) Soars: Stock Rises 17.1% - Tale of the Tape

Sinovac Biotech Ltd. Stock Upgraded (SVA)

Rev Shark: An Odd Market Day

Healthcare Stocks Pulling Out From Earlier Skid; Sinovac Biotech Climbs to 3-Year High After Q4 EPS

Healthcare Stocks Pulling Out From Earlier Skid; Sinovac Biotech Climbs to 3-Year High After Q4 EPS Beat

Sector Update: Healthcare

See More SVA News...

SVA's Top Competitors

SVA $5.50 (-0.90%)
Current stock: SVA
AMGN $121.76 (-0.88%)
Current stock: AMGN
GILD $90.56 (0.80%)
Current stock: GILD
BIIB $333.92 (-0.46%)
Current stock: BIIB